Watermark
  Back to Search Results

BGB-A317-103

Active, not recruiting

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-103

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT06091943

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20233814

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents